Advancing the economics of prevention: emerging methods and approaches.

IF 1.5 4区 医学 Q3 HEALTH CARE SCIENCES & SERVICES
Sabine E Grimm, Ghislaine van Mastrigt, Mickaël Hiligsmann
{"title":"Advancing the economics of prevention: emerging methods and approaches.","authors":"Sabine E Grimm, Ghislaine van Mastrigt, Mickaël Hiligsmann","doi":"10.1080/14737167.2025.2570689","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>There is global consensus on the critical role of prevention in improving population health and reducing long-term healthcare costs. However, investment in prevention remains comparatively limited. With governments increasingly prioritizing prevention, this may be poised to change.</p><p><strong>Areas covered: </strong>To estimate the economic value of preventive health technologies and support their prioritization for a sustainable healthcare system, we propose three essential themes for economic evaluation: recognizing the value of prevention, estimating its uncertain benefits, and enabling system-level change. We outline key objectives within each theme and highlight emerging methods and approaches to address them.</p><p><strong>Expert opinion: </strong>The key challenge ahead lies in translating these methodological advancements into policy-relevant evidence that supports effective and sustainable prevention strategies. By integrating interdisciplinary perspectives and advancing economic evaluation approaches, we can help ensure prevention receives the recognition and investment needed to foster healthier, more resilient societies.</p>","PeriodicalId":12244,"journal":{"name":"Expert Review of Pharmacoeconomics & Outcomes Research","volume":" ","pages":"1-8"},"PeriodicalIF":1.5000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Pharmacoeconomics & Outcomes Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/14737167.2025.2570689","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: There is global consensus on the critical role of prevention in improving population health and reducing long-term healthcare costs. However, investment in prevention remains comparatively limited. With governments increasingly prioritizing prevention, this may be poised to change.

Areas covered: To estimate the economic value of preventive health technologies and support their prioritization for a sustainable healthcare system, we propose three essential themes for economic evaluation: recognizing the value of prevention, estimating its uncertain benefits, and enabling system-level change. We outline key objectives within each theme and highlight emerging methods and approaches to address them.

Expert opinion: The key challenge ahead lies in translating these methodological advancements into policy-relevant evidence that supports effective and sustainable prevention strategies. By integrating interdisciplinary perspectives and advancing economic evaluation approaches, we can help ensure prevention receives the recognition and investment needed to foster healthier, more resilient societies.

推进预防经济学:新方法和途径。
导言:预防在改善人口健康和降低长期医疗保健费用方面的关键作用已成为全球共识。然而,在预防方面的投资仍然相对有限。随着各国政府越来越重视预防,这种情况可能会发生变化。涵盖领域:为了评估预防卫生技术的经济价值并支持其在可持续医疗保健系统中的优先级,我们提出了经济评估的三个基本主题:认识预防的价值,估计其不确定的利益,并使系统级变革成为可能。我们概述了每个主题中的关键目标,并强调了解决这些目标的新方法和途径。专家意见:未来的关键挑战在于将这些方法上的进步转化为支持有效和可持续预防战略的政策相关证据。通过整合跨学科的观点和推进经济评估方法,我们可以帮助确保预防得到必要的认可和投资,以促进更健康、更有复原力的社会。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Expert Review of Pharmacoeconomics & Outcomes Research
Expert Review of Pharmacoeconomics & Outcomes Research HEALTH CARE SCIENCES & SERVICES-PHARMACOLOGY & PHARMACY
CiteScore
4.00
自引率
4.30%
发文量
68
审稿时长
6-12 weeks
期刊介绍: Expert Review of Pharmacoeconomics & Outcomes Research (ISSN 1473-7167) provides expert reviews on cost-benefit and pharmacoeconomic issues relating to the clinical use of drugs and therapeutic approaches. Coverage includes pharmacoeconomics and quality-of-life research, therapeutic outcomes, evidence-based medicine and cost-benefit research. All articles are subject to rigorous peer-review. The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections: Expert Opinion – a personal view of the data presented in the article, a discussion on the developments that are likely to be important in the future, and the avenues of research likely to become exciting as further studies yield more detailed results Article Highlights – an executive summary of the author’s most critical points.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信